PDPL Intraday Analysis...

PDPL Share Price

Open 17.20 Change Price %
High 19.45 1 Day 1.10 6.53
Low 16.25 1 Week 0.25 1.41
Close 17.95 1 Month 1.05 6.21
Volume 89030 1 Year -2.95 -14.11
52 Week High 32.00
52 Week Low 16.25
PDPL Important Levels
Resistance 2 20.92
Resistance 1 19.69
Pivot 17.88
Support 1 16.21
Support 2 14.98
NSE INDIA Most Active Stocks
HDFCLIFE 344.60 18.83%
RCOM 12.10 3.42%
HDIL 63.95 7.03%
JPASSOCIAT 18.65 -0.27%
RTNPOWER 7.60 5.56%
BANKBARODA 183.55 0.41%
SUZLON 13.70 1.86%
PNB 190.80 0.63%
SBIN 337.50 1.23%
DLF 223.85 7.26%
More..
NSE INDIA Top Gainers Stocks
SUNDARAM 4.20 20.00%
NAGAROIL 3.90 20.00%
PKTEA 229.90 19.99%
PROVOGE 5.75 19.79%
HDFCLIFE 344.60 18.83%
ZUARIGLOB 227.70 14.42%
RENUKA 17.55 13.96%
MAHASTEEL 69.10 13.84%
BALAMINES 613.10 13.60%
PATINTLOG 87.90 12.84%
More..
NSE INDIA Top Losers Stocks
VIPCLOTHNG 54.30 -14.01%
SAMTEL 0.45 -10.00%
LSIL 2.05 -8.89%
WSI 6.40 -7.91%
NBIFIN 2752.40 -6.70%
PRADIP 2.20 -6.38%
MOHITIND 47.55 -6.12%
CUBEXTUB 30.40 -5.00%
PINCON 38.00 -5.00%
STCINDIA 207.20 -5.00%
More..

Parenteral Drugs (India) Limited (NSE: PDPL)

PDPL Technical Analysis 2
As on 17th Nov 2017 PDPL Share Price closed @ 17.95 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 22.68 & Buy for SHORT-TERM with Stoploss of 17.81 we also expect STOCK to react on Following IMPORTANT LEVELS.
PDPL Target for November
1st Target up-side 19.34
2nd Target up-side 20.15
3rd Target up-side 20.95
1st Target down-side 17.06
2nd Target down-side 16.25
3rd Target down-side 15.45
PDPL Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 53.99 Sideways
MFI (14) MFI is 61.48 Sideways
CCI (20) CCI is 39.60 Sideways
WILLIAM %R (14) William %R is -46.88 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 16.30
10 Day Avg Volume Traded 508.37 % More then 10 Day Average Volume
PDPL Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
PDPL Address
PDPL
N/A
Interactive Technical Analysis Chart Parenteral Drugs (India) Limited ( PDPL NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Parenteral Drugs (India) Limited
PDPL Business Profile
Parenteral Drug is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 112.11 crore.The company has reported a consolidated sales of Rs 75.90 crore and a Net Loss of Rs 13.73 crore for the quarter ended Sep 2013.The company management includes Manoharlal Gupta - Chairman, Vinod Kumar Gupta - Managing Director, Govind Das Garg - Whole Time Director, Anil Mittal - Wholetime Director & CEO, Satish Chandra Consul - Independent Director, Dharam Pal Khanna - Independent Director, Dilip Kumar Panchaity - Independent Director, Dilip Kumar Sinha - Independent Director, Satish Moreshwar Joshi - Nominee Director. It is listed on the BSE with a BSE Code of 524689 and the NSE with an NSE Code of PDPL.Its Registered office is at 340, Laxmi Plaza, Laxmi Industrial Estate,,New Link Road, Mumbai,Maharashtra - 400053.Their Registrars are Link Intime India Pvt. Ltd.